These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9862338)

  • 1. Parasite dose determines the Th1/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite.
    Menon JN; Bretscher PA
    Eur J Immunol; 1998 Dec; 28(12):4020-8. PubMed ID: 9862338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
    Bretscher PA; Ogunremi O; Menon JN
    Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-leishmania effector functions of CD4+ Th1 cells and early events instructing Th2 cell development and susceptibility to Leishmania major in BALB/c mice.
    Louis JA; Conceiçao-Silva F; Himmelrich H; Tacchini-Cottier F; Launois P
    Adv Exp Med Biol; 1998; 452():53-60. PubMed ID: 9889959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of the site of parasite inoculation on the development of Th1 and Th2 type immune responses in (BALB/c x C57BL/6) F1 mice infected with Leishmania major.
    Nabors GS; Nolan T; Croop W; Li J; Farrell JP
    Parasite Immunol; 1995 Nov; 17(11):569-79. PubMed ID: 8817603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
    Krishnan L; Guilbert LJ; Russell AS; Wegmann TG; Mosmann TR; Belosevic M
    J Immunol; 1996 Jan; 156(2):644-52. PubMed ID: 8543816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-MHC-linked Th2 cell development induced by soluble protein administration predicts susceptibility to Leishmania major infection.
    Guéry JC; Galbiati F; Smiroldo S; Adorini L
    J Immunol; 1997 Sep; 159(5):2147-53. PubMed ID: 9278301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 deficiency influences cytokine expression in susceptible BALB mice infected with Leishmania major but does not alter the outcome of disease.
    Titus RG; DeKrey GK; Morris RV; Soares MB
    Infect Immun; 2001 Aug; 69(8):5189-92. PubMed ID: 11447205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4.
    Mocci S; Coffman RL
    J Immunol; 1995 Apr; 154(8):3779-87. PubMed ID: 7706719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirements for Th1-dependent immunity against infection with Leishmania major.
    von Stebut E; Udey MC
    Microbes Infect; 2004 Oct; 6(12):1102-9. PubMed ID: 15380780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.
    Iborra S; Carrión J; Anderson C; Alonso C; Sacks D; Soto M
    Infect Immun; 2005 Sep; 73(9):5842-52. PubMed ID: 16113303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the immunological memory state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge.
    Menon JN; Bretscher PA
    Eur J Immunol; 1996 Jan; 26(1):243-9. PubMed ID: 8566074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1, but up-regulates a Th2, response in mice infected with Leishmania major.
    Mbow ML; Bleyenberg JA; Hall LR; Titus RG
    J Immunol; 1998 Nov; 161(10):5571-7. PubMed ID: 9820534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Setting in motion the immune mechanisms underlying genetically determined resistance and susceptibility to infection with Leishmania major.
    Launois P; Conceiçao-Silva F; Himmerlich H; Parra-Lopez C; Tacchini-Cottier F; Louis JA
    Parasite Immunol; 1998 May; 20(5):223-30. PubMed ID: 9651923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a strategy of universally efficacious vaccination against pathogens uniquely susceptible to cell-mediated attack.
    Bretscher PA; Menon JN; Ogunremi O
    J Biotechnol; 1996 Jan; 44(1-3):1-4. PubMed ID: 8717379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes.
    Lipoldová M; Svobodová M; Krulová M; Havelková H; Badalová J; Nohýnková E; Holán V; Hart AA; Volf P; Demant P
    Genes Immun; 2000 Feb; 1(3):200-6. PubMed ID: 11196712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JNK1 is required for T cell-mediated immunity against Leishmania major infection.
    Constant SL; Dong C; Yang DD; Wysk M; Davis RJ; Flavell RA
    J Immunol; 2000 Sep; 165(5):2671-6. PubMed ID: 10946297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cells have no impact on cutaneous leishmaniasis severity and related Th2 differentiation in resistant and susceptible mice.
    Paul C; Wolff S; Zapf T; Raifer H; Feyerabend TB; Bollig N; Camara B; Trier C; Schleicher U; Rodewald HR; Lohoff M
    Eur J Immunol; 2016 Jan; 46(1):114-21. PubMed ID: 26449668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal expression of I-TAC (Cxcl11) instructs adaptive Th2-type immunity.
    Roebrock K; Sunderkötter C; Münck NA; Wolf M; Nippe N; Barczyk K; Varga G; Vogl T; Roth J; Ehrchen J
    FASEB J; 2014 Apr; 28(4):1724-34. PubMed ID: 24398292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inbred strains derived from feral mice reveal new pathogenic mechanisms of experimental leishmaniasis due to Leishmania major.
    Babay BE; Louzir H; Kebaïer C; Boubaker S; Dellagi K; Cazenave PA
    Infect Immun; 2004 Aug; 72(8):4603-11. PubMed ID: 15271920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host susceptibility factors to cutaneous leishmaniasis.
    Jones DE; Elloso MM; Scott P
    Front Biosci; 1998 Nov; 3():D1171-80. PubMed ID: 9820738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.